- 1Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
- 2Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
- 3Clinics of Internal Diseases and Family Medicine, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Background: Poor sleep quality is associated with different physical and mental health diseases. It is proposed that increased hypothalamic-pituitary-adrenal axis activity is a potential contributor affecting sleep pattern and quality. We aimed to analyze the relationship between subjective sleep quality indicators and hair glucocorticoid levels among relatively healthy perimenopausal and postmenopausal women.
Methods: A total of 145 women aged 50–64 y.o. were enrolled in the cross-sectional pilot study. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index, while stress level was measured using the Perceived Stress Scale. Hair cortisol and cortisone levels were determined by ultra-high-performance liquid chromatography-tandem mass spectrometry.
Results: Statistically significant positive relationship was found between hair cortisol concentration and Pittsburgh sleep quality index score. Similarly, statistically significant positive associations were observed between hair total glucocorticoid level and Pittsburgh sleep quality index, sleep disturbance, and Perceived Stress Scale scores. Subjects with prolonged sleep latency had significantly higher hair cortisol and total hair glucocorticoid concentrations compared with individuals whose sleep latency is not disturbed. Additionally, Chi-squared test indicated that lower hair cortisol concentration was significantly related to better sleep efficiency.
Conclusion: Increased hair glucocorticoid (cortisol, cortisone) levels were found to be related with worse sleep quality measured by Pittsburgh sleep quality index score.
1 Introduction
Poor sleep behaviour can cause changes in mood and reduce alertness and cognitive performance, and even can be associated with an increased risk of mental health disorders (1). Despite the fact that mental health problems in women have long been underinvestigated, several studies have shown that various social factors such as difficulties in maintaining a balance between work and home, stress or sleep disorders can be associated with an increased risk of developing mental health problems (2, 3). It is suggested that dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has an impact on the mental health and might be involved in the pathway linking poor sleep quality and mental health disorders (1). Although previous studies showed that different stress-related disorders, including posttraumatic stress disorder (PTSD) (4), depression (5) and adjustment disorder (6) are closely related to elevated levels of glucocorticoid (cortisol, cortisone) levels and aberrant glucocorticoid signalling, there are data that do not fully support this hypothesis. Results of the systematic review conducted by Staufenbiel et al. (7) showed that hair cortisol concentration was increased in patients with major depression while patients with anxiety, including generalized anxiety disorder and panic disorder, had significantly lower hair cortisol level compared with the control group. Furthermore, in patients with bipolar disorders, the cortisol level increased only in individuals with a late age of onset.
Menopause is a period when women are especially prone to develop sleep disorders (8, 9). It is suggested that menopausal women are 3.4 times more likely to report sleep disorders compared with the premenopausal women (8). The cessation of ovarian endocrinological function during menopause results in significantly decreased estrogen and progestogen secretion and these alterations are related to other physical, physiological, and psychological changes that possibly have an impact on sleep quality (9). Although hormonal changes are the primary factors associated with the sleep disturbances, the etiology of sleep disorders in menopausal women are not fully elucidated. It is speculated that vasomotor symptoms, psychosocial factors, or medical conditions such as cardiovascular, neurological, endocrine diseases might be important contributors toward increased risk of sleep disorders in menopausal women (8).
Hypothalamic-pituitary-adrenal (HPA) axis dysfunction is suggested to play a role in the development of sleep disorders, while on the other hand it might be the result of the sleep disorder (10). HPA axis hyperactivity might lead to fragmentation of sleep, decreased slow-wave sleep, shortened sleep time while sleep fragmentation and sleep deprivation can exacerbate HPA axis dysfunction (11). Chronic insomnia without depression occurs with elevated cortisol levels in the evening – this rise in cortisol level may be a primary cause of the sleep disturbance (12). The results of recently published data showed that people who report recurring sleep problems have a higher level of cortisol throughout the day and the total duration of sleep is negatively correlated with circulating cortisol throughout the day. Experimental sleep disturbance in the form of repeated excitations during bedtime induces increased HPA axis activity and results in higher cortisol levels the next day. Additionally, individuals who report fewer sleep disturbances demonstrate a flatter slope of cortisol throughout the day (13, 14).
Previous research mostly relied on cortisol analysis in blood, urine and saliva which accurately reflects changes in cortisol levels at the time of sampling, potentially influenced by daily fluctuations but they are not applicable to measure long-term changes in cortisol concentration (7, 15, 16). Investigation of hormones in serum or plasma samples allows to evaluate the level of cortisol during sleep but this method requires the usage of an intravenous cannula that itself can be a stressor influencing cortisol levels and sleep parameters. Moreover, the sampling of blood at short time intervals generally limits the assessment to unnatural laboratory conditions and to a small number of nights that may not reflect natural changes in sleep pattern. Urine and saliva samples for cortisol and cortisone measurement can easily be collected at home across a longer time period and at specific time points close to the sleep period, thus allowing for the assessment of the consequences of disturbed sleep on the HPA axis activity (17). In the last decade, analysis of cortisol in scalp hair was found to be the most promising methodological approach for assessing long-term HPA axis activity, a biomarker of chronic stress level, and its association with sleep disorders (10). The main advantage of using hair cortisol as a biomarker of chronic HPA axis activity compared with other specimens (i.e., blood serum, saliva, urine) is the fairly predictable growth rate (1 cm/month) that allows retrospective assessment of integrated cortisol secretion during the period from 1 to 6 months (7, 15, 16). Measurement of hair glucocorticoid levels is a compelling instrument to assess long-term cortisol secretion, however, until now, most studies focused on the link between cortisol and chronic stress (18) or psychopathologies, including post-traumatic stress disorder (19), major depression (20) and bipolar disorder (21). The current study aimed to analyze the relationship between subjective sleep quality indicators and hair glucocorticoid levels among relatively healthy perimenopausal and postmenopausal women.
2 Materials and methods
2.1 Study participants
The minimum sample size calculated using the open-access program G*Power (version 3.1) was 145 individuals (the a priori selected research significance level α = 0.05 and the research power - 80%). Thus, the cross-sectional pilot study included 145 consecutively selected apparently healthy females (50–64 y.o.) participating in the national cardiovascular disease prevention program. Subjects were recruited and data were collected between September 2020 and May 2021. The data presented in the current study (sleep quality, stress, anxiety measures and hair glucocorticoid levels) were collected in another study which aimed to evaluate the association between chronic stress biomarkers (hair glucocorticoids) or subjective stress measures (questionnaires) and the prevalence of cardiovascular disease risk factors, as well as 10-year risk of cardiovascular disease. Exclusion criteria were the presence of acute and chronic diseases, including cardiovascular disease, diabetes mellitus and chronic kidney disease, as well as mental diseases and the use of synthetic steroid hormones during the previous 3 months. Participants provided written informed consent before entering the study. The study protocol was approved by the Vilnius Regional Biomedical Research Ethics Committee (No. 2020/8-1254-735). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
2.2 Glucocorticoid analysis in hair samples
Hair glucocorticoid (cortisol and cortisone) levels were determined from the most proximal 3 cm segment of scalp hair collected from the posterior vertex region of the head. A sample preparation procedure was performed using a slightly modified method, as published in our previous paper (22). Chromatographic separation was performed on an ultra-high performance liquid chromatography (UHPLC) system consisting of two Shimadzu LC-30AD binary pumps, a Shimadzu SIL30AC autosampler, and a Shimadzu CTO-20AC column oven (Shimadzu Corporation, Kyoto, Japan). The UHPLC was coupled with a Shimadzu LCMS8060 triple quadrupole tandem mass spectrometer equipped with an electrospray ionization source (Shimadzu Corporation, Kyoto, Japan), which was operated in the positive ionization mode.
Since hair washing frequency is a potential confounder affecting hair glucocorticoid concentrations (23), we divided study participants into three groups based on hair washing frequency (≤1/week, 2–4/week, >5/week) and compared hair glucocorticoid levels between these groups. The results showed no statistically significant differences in hair cortisol (2.62 (2.51) ng/g, 3.69 (6.36) ng/g, 4.06 (16.04) ng/g, p = 0.134, respectively), cortisone (6.76 (5.12) ng/g, 6.61 (4.23) ng/g, 6.07 (5.86) ng/g, p = 0.966, respectively), and total glucocorticoid (12.22 (14.40) ng/g, 10.46 (13.15) ng/g, 8.78 (6.95) ng/g, p = 0.136, respectively) median values among the groups.
2.3 Sociodemographic and lifestyle characteristics
Each subject was asked to complete a questionnaire to collect sociodemographic information (i.e., age, marital status, education) and data on lifestyle factors (i.e., physical activity at work and in leisure, smoking status). The physical activity level of the participants was measured using a four-category rating scale. Score 1 of physical activity at work was described as mainly sedentary work, eg, sitting at a desk; Score 2 – necessary to walk during work without lifting heavy items, eg, working in customer service, teaching; Score 3 – intensive walking during work, carrying heavy items, eg, postman’s work, industrial work; Score 4 – intense heavy physical work, lifting heavy items, eg, the work of a nurse. Score 1 of physical activity at leisure time was described as time mainly spent for reading, watching TV or theatrical performances, etc.; Score 2 – going for a walk or cycling at least 4 times per week, light work in the garden, fishing, bowling etc.; Score 3 – at least three times a week time mainly spent running, swimming, playing tennis or some other similar sport; Score 4 – mainly heavy training, running, swimming, skiing, participating regularly in matches a couple of times a week. Subjects were asked to rate their physical activity by selecting one statement from four to best describe their physical activity.
2.4 Sleep quality, psychosocial stress and anxiety measures
The Pittsburgh Sleep Quality Index (PSQI) was created to assess sleep quality and disturbances over the past month. The PSQI consists of 19 questions divided into 7 domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications and daytime dysfunction. Each component yields a score ranging from 0 to 3 points, where 0-1 points mean no dysfunction (good sleep quality), and 2-3 points indicate the sleep dysfunction (poor sleep quality). The sleep component scores are summed to yield a total score ranging from 0 to 21 with higher scores indicating worse sleep quality. It is estimated that a global PSQI index score lower than 5 indicates good sleep quality, while a value equal to or higher than 5 means poor sleep quality (24).
Perceived Stress Scale (PSS) is a stress assessment instrument designed to measure the degree to which situations in the life of a subject are considered stressful. Possible total PSS scores can range from 0 to 40 with higher scores indicating a higher perceived stress level. Scores ranging from 0-13 would be considered low stress, 14-26 would be considered moderate stress, and 27-40 would be considered high perceived stress (25). Anxiety level was assessed by the trait scale of the State-Trait Anxiety Inventory (STAI-T). Overall STAI-T scores range from 20 to 80, with higher scores indicating a greater trait anxiety level (26).
2.5 Statistical analysis
Statistical analysis was performed using the R software (version 2.4.0). The Shapiro-Wilk test was used to test the normality of the variables. Comparison of median values (IQR) between the two groups was performed using the Mann-Whitney U test. Comparison of median values (IQR) among three or more groups was performed using the Kruskal-Wallis test. Spearman’s correlation coefficients were used to quantify the strength of the correlation between variables. The correlation was considered as a very weak (r ≤ 0.19), weak (0.20 ≤ r ≤ 0.39), moderate (0.40 ≤ r ≤ 0.69), strong (0.70 ≤ r ≤ 0.89) and very strong (0.90 ≤ r ≤ 1.00). To test the hypothesis of independence between categorical variables Pearson’s χ2 test or Fisher’s exact test (when expected frequencies lower than 5) was performed. The level of statistical significance was set at 0.05 for the two-tailed test.
3 Results
3.1 Study group characteristics
Self-reported data showed that most subjects were married (73.79%) and achieved higher education (84.14%). Also, the majority of participants were non-smokers (88.97%) and non-exposed to passive smoking (92.41%). More than half of subjects (59.03%) were inactive during working hours, but most individuals preferred walking and active lifestyle during leisure-time. Also, the majority of women (81.38%) reported being in the menopausal phase, 17.93% were peri-menopausal and one woman (0.69%) did not provide information about the peri/post-menopausal status. Furthermore, none of the study participants were using estrogen therapy. The sociodemographic and lifestyle characteristics of the study sample are shown in Table 1.
3.2 Association between Pittsburgh Sleep Quality Index, Perceived Stress Scale, and Hair Glucocorticoid Levels
The median (IQR) values of hair cortisol, cortisone and total glucocorticoid levels were 3.58 (6.76) ng/g, 6.69 (4.95) ng/g and 10.31 (12.17) ng/g, respectively. The comparison of hair steroid hormone concentrations among groups based on different sleep quality and self-reported stress level is reported in Table 2.
Table 2 Comparison of hair cortisol, cortisone and total glucocorticoid level median values between the groups based on sleep quality indicators and perceived stress level.
The results showed that subjects with increased sleep latency had significantly higher hair cortisol and total hair glucocorticoid concentrations compared with individuals whose sleep latency is not disturbed. Differences in hair steroid hormone levels among the groups based on the other PSQI components (subjective sleep quality, sleep duration, sleep efficiency, sleep disturbance, use of sleep medication, daytime dysfunction), total PSQI score, and perceived stress level were found to be non-statistically significant.
Correlation analyses revealed a weak but statistically significant positive association between hair cortisol concentration and Pittsburgh sleep quality index score. Similarly, statistically significant positive correlations were found between total glucocorticoid level and sleep disturbance, Pittsburgh sleep quality index, and perceived stress scale scores in the current study (Table 3).
Table 3 Correlations of hair cortisol, cortisone and total glucocorticoid levels with sleep quality indicators, perceived stress and anxiety level.
Since there are no generally accepted reference values of hair glucocorticoid levels, we divided the entire study population into two groups based on the median values of hair cortisol, cortisone and glucocorticoid (the sum of cortisol and cortisone) levels. The results of the chi-squared test indicated that higher hair cortisol and cortisone concentrations were associated with the longer sleep latency indicating worse sleep quality. Also, lower hair cortisol concentration was significantly related to better sleep efficiency (Table 4).
Table 4 Sleep quality and perceived stress indicators among the subject groups based on hair cortisol, cortisone and total glucocorticoid median values.
4 Discussion
The main finding in the current study is the positive correlation between hair cortisol, as well as the sum of cortisol and cortisone, and the total score of the Pittsburgh Sleep Quality Index. Furthermore, a more detailed analysis of the PSQI components revealed significant associations of higher hair cortisol levels with longer sleep latency and poorer sleep efficiency, while a higher hair cortisone level was related to prolonged sleep latency. The total glucocorticoid level (the sum of cortisol and cortisone) was associated with increased sleep disturbance. Cortisol is converted to biologically inactive cortisone by the enzymatic reaction catalysed by the 11β-hydroxysteroid dehydrogenase type 2 (27). Thus, there is a strong biological rationale to measure both hair cortisol and cortisone, as well as the total level of these steroids because it might better reflect HPA axis activity and chronic stress level (28).
Sleep latency, which is defined as the time period in which the patient attempts to sleep until the patient actually falls asleep, is considered one of the most important parameters in studying sleep quality (29). Tell et al. (30) analysed day-to-day variations in sleep behaviours and cortisol diurnal rhythm in women with a diagnosis of early-stage breast cancer and found that longer sleep latency was a predictor of increased salivary cortisol decline from wake-up to bedtime while higher total PSQI score was related to a flatter cortisol linear slope. The flat slope of the diurnal cortisol is estimated to be an indicator of dysregulation of the HPA axis and is associated with the occurrence of physical and mental health problems (31). Another study examining the link between sleep latency and hair cortisol level focused on the paediatric population and reported no significant relationship between long-term cortisol exposure and objectively measured sleep latency (32). Sleep efficiency is another essential indicator that reflects the percentage of total time in bed spent actually sleeping and poor sleep efficiency is mainly related to prolonged sleep latency (29). Studies investigating the association between sleep efficiency and HPA axis activity showed inconsistent results: Räikkönen et al. (33) reported that 8-year-old children with low sleep efficiency had increased cortisol secretion throughout the day while Maurer et al. (34) and Eythorsdottir et al. (32) showed no association of post-awakening cortisol secretion or hair cortisol level and objectively measured sleep efficiency in school-aged or pre-school children. Similarly, a cross-sectional study involving 335 apparently healthy women (72.2% of participants younger than 42 y. o.) found no relationship between salivary cortisol levels in the morning or at bedtime and total PSQI, as well as seven different PSQI domains (2).
It is evident that the aforementioned studies focused on pediatric and young adult populations. However, it is estimated that after the age of 40 years the amount of slow wave sleep decreases, wakefulness during bedtime increases and these factors contribute to the increased risk of developing chronic insomnia or other sleep disorders (17). The large cross-sectional study using the data from the Whitehall II study examined the link between subjectively evaluated sleep disturbances and salivary cortisol awakening response or the slope of diurnal cortisol secretion in a community-based cohort of more than 2700 middle-aged men and women. The results showed that short sleep duration and increased sleep disturbances are related to a shallow diurnal cortisol slope with significantly raised cortisol secretion in the evening (35). Since most studies evaluated HPA axis activity by measuring salivary cortisol level, it is necessary to investigate long-term alterations in basal HPA axis activity and its association with the sleep quality indicators. A recently published paper demonstrated that hair cortisol concentration had a mediating effect between shift work and sleep disorders which were diagnosed if the total score of PSQI was higher than 7 (36). Similarly, Wang et al. reported that hair cortisol concentration was a mediator of the association between work burnout and insomnia (37). The results of our study support the hypothesis that poor sleep quality is related to the increased HPA axis activity and the statistically significant association of hair cortisone level with sleep latency emphasizes the importance of cortisone, the inactive form of cortisol, analysis in order to gain the more precise information about the HPA axis activity.
We also found very weak but statistically significant positive correlation between Perceived stress scale scores and total glucocorticoid level. However, no statistically significant differences of hair cortisol, cortisone and total glucocorticoid median values were observed among PSS groups (low, moderate, high stress level). These findings are consistent with the previous research. Olstad et al. (38) reported no statistically significant association between PSS scores and hair cortisol concentration in women living in socioeconomically disadvantaged neighborhoods. Similarly, O’Brien et al. (39) also found no significant relationship between personal stress evaluated using PSS and hair cortisol concentration in a diverse population of 135 adults.
The study has several limitations that need to be addressed in future research. First, the cross-sectional study design does not provide information about causality in the relationship between sleep quality indicators and hair glucocorticoid levels. However, it is suggested that there is a reciprocal relationship because experimental data showed that sleep deprivation stimulated HPA axis while increased glucocorticoid concentration results in nocturnal awakenings and disturbed sleep (33). Second, there is no standardized method for the measurement of hair glucocorticoid levels and the reference values of hair cortisol and cortisone levels are not available. Third, we evaluated individuals’ sleep quality using PSQI but for the more comprehensive information about the sleep quality objective methods such as polysomnographic measures can be used in future studies. Furthermore, the study population consisted of apparently healthy middle-aged women participating in the national cardiovascular disease prevention program. Thus, our study group might not represent the general female population and the findings of the study should be confirmed in a more heterogeneous study group. Finally, it should be noted that in the context of sleep quality and its associations with hair glucocorticoid levels, which are highly variable among individual subjects, our sample size is insufficient as a post hoc analysis of the statistical power showed that our research power was 70%. The results of this pilot study should be confirmed and extended by conducting a study with larger sample size including peri/post-menopausal women with objectively evaluated good and poor sleep quality, as well as more detailed information about the frequency and severity of vasomotor symptoms among study participants.
5 Conclusions
Higher hair glucocorticoid (cortisol, cortisone) levels were found to be related with the poor subjectively perceived sleep quality as elevated levels of glucocorticoids were associated with the higher total score of Pittsburgh Sleep Quality Index and its components including sleep latency, sleep efficiency and sleep disturbance. These results indicate that regardless of the direction of the association increased HPA axis activity and reduced sleep quality are highly interconnected.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and approved by Vilnius Regional Biomedical Research Ethics Committee (No. 2020/8-1254-735). The patients/participants provided their written informed consent to participate in this study.
Author contributions
EM and AV contributed to writing the original draft. DK, NB, JS and AU contributed to review and editing the draft. EM, AV, NB and DK contributed to the formal analysis and interpretation of the results. EM and DK contributed to study design and conceptualization. All authors contributed to the article and approved the submitted version.
Funding
Open access publication fee is funded by Vilnius University.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Bassett SM, Lupis SB, Gianferante D, Rohleder N, Wolf JM. Sleep quality but not sleep quantity effects on cortisol responses to acute psychosocial stress. Stress (2015) 18:638–44. doi: 10.3109/10253890.2015.1087503
2. Bani-Issa W, Radwan H, Al Marzooq F, Al Awar S, Al-Shujairi AM, Samsudin AR, et al. Salivary cortisol, subjective stress and quality of sleep among female healthcare professionals. J Multidiscip Healthc (2020) 13:125–40. doi: 10.2147/JMDH.S229396
3. Silverio SA. Women’s mental health as a public health priority: a call for action. J Public Ment Health (2021) 20:60–8. doi: 10.1108/JPMH-04-2020-0023
4. Steudte S, Kolassa IT, Stalder T, Pfeiffer A, Kirschbaum C, Elbert T. Increased cortisol concentrations in hair of severely traumatized Ugandan individuals with PTSD. Psychoneuroendocrinology (2011) 36:1193–200. doi: 10.1016/j.psyneuen.2011.02.012
5. Dettenborn L, Muhtz C, Skoluda N, Stalder T, Steudte S, Hinkelmann K, et al. Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress (2012) 15:348–53. doi: 10.3109/10253890.2011.619239
6. Tripodianakis J, Markianos M, Sarantidis D, Leotsakou C. Neurochemical variables in subjects with adjustment disorder after suicide attempts. Eur Psychiatry (2000) 15:190–5. doi: 10.1016/S0924-9338(00)00226-1
7. Staufenbiel SM, Penninx BWJH, Spijker AT, Elzinga BM, van Rossum EFC. Hair cortisol, stress exposure, and mental health in humans: a systematic review. Psychoneuroendocrinology (2013) 38:1220–35. doi: 10.1016/j.psyneuen.2012.11.015
8. Guidozzi F. Sleep and sleep disorders in menopausal women. Climacteric (2013) 16:214–9. doi: 10.3109/13697137.2012.753873
9. Xu M, Bélanger L, Ivers H, Guay B, Zhang J, Morin CM. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med (2011) 12:65–9. doi: 10.1016/j.sleep.2010.09.003
10. Mlili NE, Ahabrach H, Cauli O. Hair cortisol concentration as a biomarker of sleep quality and related disorders. Life (2021) 11:1–19. doi: 10.3390/life11020081
11. Buckley TM, Schatzberg AF. Review: on the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab (2005) 90:3106–14. doi: 10.1210/jc.2004-1056
13. Kuhlman KR, Chiang JJ, Bower JE, Irwin MR, Seeman TE, McCreath HE, et al. Sleep problems in adolescence are prospectively linked to later depressive symptoms via the cortisol awakening response. Dev Psychopathol (2020) 32:997–1006. doi: 10.1017/S0954579419000762
14. Elder GJ, Wetherell MA, Barclay NL, Ellis JG. The cortisol awakening response - applications and implications for sleep medicine. Sleep Med Rev (2014) 18:215–24. doi: 10.1016/j.smrv.2013.05.001
15. Feller S, Vigl M, Bergmann MM, Boeing H, Kirschbaum C, Stalder T. Predictors of hair cortisol concentrations in older adults. Psychoneuroendocrinology (2014) 39:132–40. doi: 10.1016/j.psyneuen.2013.10.007
16. Greff MJE, Levine JM, Abuzgaia AM, Elzagallaai AA, Rieder MJ, van Uum SHM. Hair cortisol analysis: an update on methodological considerations and clinical applications. Clin Biochem (2019) 63:1–9. doi: 10.1016/j.clinbiochem.2018.09.010
17. Backhaus J, Junghanns K, Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology (2004) 29:1184–91. doi: 10.1016/j.psyneuen.2004.01.010
18. Russell E, Koren G, Rieder M, Van Uum S. Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2012) 37:589–601. doi: 10.1016/j.psyneuen.2011.09.009
19. Steudte S, Kirschbaum C, Gao W, Alexander N, Schönfeld S, Hoyer J, et al. Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol Psychiatry (2013) 74:639–46. doi: 10.1016/j.biopsych.2013.03.011
20. Psarraki EE, Kokka I, Bacopoulou F, Chrousos GP, Artemiadis A, Darviri C. Is there a relation between major depression and hair cortisol? a systematic review and meta-analysis. Psychoneuroendocrinology (2021) 124:105098. doi: 10.1016/j.psyneuen.2020.105098
21. Coello K, Munkholm K, Nielsen F, Vinberg M, Kessing LV. Hair cortisol in newly diagnosed bipolar disorder and unaffected first-degree relatives. Psychoneuroendocrinology (2019) 99:183–90. doi: 10.1016/j.psyneuen.2018.09.020
22. Mažeikienė A, Bekesiene S, Karčiauskaitė D, Mazgelytė E, Larsson G, Petrėnas T, et al. The association between endogenous hair steroid hormones and social environmental factors in a group of conscripts during basic military training. Int J Environ Res Public Health (2021) 18:1–18. doi: 10.3390/ijerph182212239
23. Staufenbiel SM, Penninx BWJH, de Rijke YB, van den Akker ELT, van Rossum EFC. Determinants of hair cortisol and hair cortisone concentrations in adults. Psychoneuroendocrinology (2015) 60:182–94. doi: 10.1016/j.psyneuen.2015.06.011
24. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 28:193–213. doi: 10.1016/0165-1781(89)90047-4
25. Cohen S, Kamarck T, Mermelsten R. A global measure of perceived stress. J Health Soc Behav (1983) 24:385–96. doi: 10.2307/2136404
26. Spielberger CD. Manual for the state-trait anxiety inventory (STAI). Menlo Park, CA: Mind Garden, Inc (1968) p. 1–10.
27. Raul J-S, Cirimele V, Ludes B, Kintz P. Detection of physiological concentrations of cortisol and cortisone in human hair. Clin Biochem (2004) 37:1105–11. doi: 10.1016/j.clinbiochem.2004.02.010
28. Vanaelst B, Rivet N, Huybrechts I, Ludes B, De Henauw S, Raul JS. Measurement of cortisol and cortisone in children’s hair using ultra performance liquid chromatography and tandem mass spectrometry. Anal Methods (2013) 5:2074–82. doi: 10.1039/c3ay26570f
29. Shrivastava D, Jung S, Saadat M, Sirohi R, Crewson K. How to interpret the results of a sleep study. J Community Hosp Intern Med Perspect (2014) 4:24983. doi: 10.3402/jchimp.v4.24983
30. Tell D, Mathews HL, Janusek LW. Day-to-day dynamics of associations between sleep, napping, fatigue, and the cortisol diurnal rhythm in women diagnosed as having breast cancer. Psychosom Med (2014) 76:519–28. doi: 10.1097/PSY.0000000000000097
31. Incollingo Rodriguez AC, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ. Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review. Psychoneuroendocrinology (2015) 62:301–18. doi: 10.1016/j.psyneuen.2015.08.014
32. Eythorsdottir DY, Frederiksen P, Larsen SC, Olsen NJ, Heitmann BL. Associations between objective measures of physical activity, sleep and stress levels among preschool children. BMC Pediatr (2020) 20:1–7. doi: 10.1186/s12887-020-02108-7
33. Räikkönen K, Matthews KA, Pesonen AK, Pyhälä R, Paavonen EJ, Feldt K, et al. Poor sleep and altered hypothalamic-pituitary-adrenocortical and sympatho-adrenal-medullary system activity in children. J Clin Endocrinol Metab (2010) 95:2254–61. doi: 10.1210/jc.2009-0943
34. Maurer N, Perkinson-Gloor N, Stalder T, Hagmann-von Arx P, Brand S, Holsboer-Trachsler E, et al. Salivary and hair glucocorticoids and sleep in very preterm children during school age. Psychoneuroendocrinology (2016) 72:166–74. doi: 10.1016/j.psyneuen.2016.07.003
35. Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T. Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab (2009) 94:4801–9. doi: 10.1210/jc.2009-0555
36. Zhang Y, Shen J, Zhou Z, Sang L, Zhuang X, Chu M, et al. Relationships among shift work, hair cortisol concentration and sleep disorders: a cross-sectional study in China. BMJ Open (2020) 10. doi: 10.1136/bmjopen-2020-038786
37. Wang C, Dai J, Li J. Mediating effects of hair cortisol on the mutual association of job burnout and insomnia: a retrospective exploratory study. J Psychiatr Res (2019) 117:62–7. doi: 10.1016/j.jpsychires.2019.07.001
38. Olstad DL, Ball K, Wright C, Abbott G, Brown E, Turner AI. Hair cortisol levels, perceived stress and body mass index in women and children living in socioeconomically disadvantaged neighborhoods: the READI study. Stress (2016) 19:158–67. doi: 10.3109/10253890.2016.1160282
Keywords: hair glucocorticoids, cortisol, cortisone, sleep quality, Pittsburgh sleep quality index
Citation: Mazgelytė E, Valatkevičiūtė A, Songailienė J, Utkus A, Burokienė N and Karčiauskaitė D (2023) Association of hair glucocorticoid levels with sleep quality indicators: a pilot study in apparently healthy perimenopausal and menopausal women. Front. Endocrinol. 14:1186014. doi: 10.3389/fendo.2023.1186014
Received: 14 March 2023; Accepted: 25 May 2023;
Published: 17 July 2023.
Edited by:
T. John Wu, Uniformed Services University of the Health Sciences, United StatesReviewed by:
Margaret F. Keil, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH), United StatesJoanna Spencer-Segal, University of Michigan, United States
Copyright © 2023 Mazgelytė, Valatkevičiūtė, Songailienė, Utkus, Burokienė and Karčiauskaitė. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Eglė Mazgelytė, ZWdsZS5tYXpnZWx5dGVAbWYudnUubHQ=